Zobrazeno 1 - 10
of 692
pro vyhledávání: '"Masayuki, Nakagawa"'
Autor:
Wataru Fukumoto, Shunsuke Okamura, Motoki Tamai, Junya Arima, Ichiro Kawahara, Ikumi Fukuda, Akihiko Mitsuke, Takashi Sakaguchi, Satoshi Sugita, Ryosuke Matsushita, Shuichi Tatarano, Yasutoshi Yamada, Masayuki Nakagawa, Hideki Enokida, Hirofumi Yoshino
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Chemotherapy including cisplatin is recommended for the treatment of advanced bladder cancer, but its effectiveness is limited due to the acquisition of drug resistance. Although several mechanisms of cisplatin resistance have bee
Externí odkaz:
https://doaj.org/article/7d46651dce6b448899636a311a74c173
Autor:
Ichiro Kawahara, Hirofumi Yoshino, Wataru Fukumoto, Junya Arima, Saeki Saito, Gang Li, Ikumi Fukuda, Akihiko Mitsuke, Takashi Sakaguchi, Satoru Inoguchi, Ryosuke Matsushita, Masayuki Nakagawa, Shuichi Tatarano, Yasutoshi Yamada, Hideki Enokida
Publikováno v:
Molecular Oncology, Vol 18, Iss 9, Pp 2196-2211 (2024)
Gemcitabine plus cisplatin (GC) combination chemotherapy is the primary treatment for advanced bladder cancer (BC) with unresectable or metastatic disease. However, most cases develop resistance to this therapy. We investigated whether drug resistanc
Externí odkaz:
https://doaj.org/article/c2d8257116da49f8983df134c431822c
Autor:
Hirofumi Yoshino, Seiya Yokoyama, Motoki Tamai, Shunsuke Okamura, Sayaka Iizasa, Takashi Sakaguchi, Yoichi Osako, Satoru Inoguchi, Ryosuke Matsushita, Yasutoshi Yamada, Masayuki Nakagawa, Shuichi Tatarano, Akihide Tanimoto, Hideki Enokida
Publikováno v:
FEBS Open Bio, Vol 13, Iss 6, Pp 1056-1066 (2023)
Combination chemotherapy with gemcitabine and cisplatin (GC) is recommended as the primary treatment for advanced bladder cancer (BC). However, the benefits of this approach are limited owing to the acquisition of drug resistance. Here, we found that
Externí odkaz:
https://doaj.org/article/720e8450134c49778a8939c7650a0022
Autor:
Ryota Yanaizumi, Yusuke Nagamine, Shinsuke Harada, Tomoko Kuramochi, Shuhei Ota, Yoichiro Abe, Masayuki Nakagawa, Kenya Kamijima, Maya Hayashi, Toshiharu Tazawa, Kenichi Ogawa, Takahisa Goto
Publikováno v:
Pain and Therapy, Vol 12, Iss 3, Pp 825-840 (2023)
Abstract Introduction The celiac plexus block is effective for treating intractable cancer pain and has been the focus of many studies. At our affiliated institution, fluoroscopy-guided splanchnic nerve block with a single needle via the transinterve
Externí odkaz:
https://doaj.org/article/abb208a8d60d49b1b433312e1ceea49d
Autor:
Tomoyuki Hayashi, Kenji Yoshida, Chiharu Tamura, Yoshio Miyazawa, Masahiko Sato, Taito Miyamoto, Masayuki Nakagawa
Publikováno v:
IJU Case Reports, Vol 6, Iss 2, Pp 107-110 (2023)
Introduction Metastasectomy of oligometastatic prostate cancer has the potential to contribute to improving prognosis. We report on a case of metastasectomy of solitary liver tumor after radical prostatectomy. Case presentation An 80‐year‐old man
Externí odkaz:
https://doaj.org/article/d267d2f667a241a8b91c2a366d5f74af
Autor:
Shintaro Hagihara, Masayuki Nakagawa, Kana Matsubara, Kohei Godai, Kenya Kamijima, Yoichiro Abe
Publikováno v:
JA Clinical Reports, Vol 8, Iss 1, Pp 1-6 (2022)
Abstract Background Complex anatomical features are challenging for minimally invasive intradiscal therapy owing to insufficient visualization for accurate needle advancement. We report the case of a patient with dysraphic vertebral pathologies who p
Externí odkaz:
https://doaj.org/article/536da2e6ca364196ab755c26c3467ad5
Autor:
Makito Miyake, Kota Iida, Nobutaka Nishimura, Takashi Inoue, Hiroaki Matsumoto, Hideyasu Matsuyama, Yuya Fujiwara, Kazumasa Komura, Teruo Inamoto, Haruhito Azuma, Hiroaki Yasumoto, Hiroaki Shiina, Masaya Yonemori, Hideki Enokida, Masayuki Nakagawa, Hideo Fukuhara, Keiji Inoue, Takashi Yoshida, Hidefumi Kinoshita, Tadashi Matsuda, Tomomi Fujii, Kiyohide Fujimoto
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 95-104 (2022)
Background: Site-specific postoperative risk models for localized upper tract urothelial carcinoma (UTUC) are unavailable. Objective: To create specific risk models for renal pelvic urothelial carcinoma (RPUC) and ureteral urothelial carcinoma (UUC),
Externí odkaz:
https://doaj.org/article/9e2f1052af52442ba6e77957eac8e055
Autor:
Motoki Tamai, Shuichi Tatarano, Shunsuke Okamura, Wataru Fukumoto, Issei Kawakami, Yoichi Osako, Takashi Sakaguchi, Satoshi Sugita, Masaya Yonemori, Yasutoshi Yamada, Masayuki Nakagawa, Hideki Enokida, Hirofumi Yoshino
Publikováno v:
Molecular Oncology, Vol 16, Iss 6, Pp 1329-1346 (2022)
Patients with advanced bladder cancer are generally treated with a combination of chemotherapeutics, including gemcitabine, but the effect is limited due to acquisition of drug resistance. Thus, in this study, we investigated the mechanism of gemcita
Externí odkaz:
https://doaj.org/article/c55b1c48d9a940969d81190a0f2acebb
Autor:
Masayuki Nakagawa1 nakagawa.masayuki@nihon-u.ac.jp, Chihiro Shimizu2 c.shimizu@r.hit-u.ac.jp
Publikováno v:
International Real Estate Review. Winter2023, Vol. 26 Issue 4, p463-488. 26p.
Autor:
Shuichi Tatarano, Hideki Enokida, Masaya Yonemori, Rumiko Eura, Hirofumi Yoshino, Hiroaki Nishimura, Yasutoshi Yamada, Masayuki Nakagawa
Publikováno v:
Investigative and Clinical Urology, Vol 62, Iss 2, Pp 166-171 (2021)
Purpose: Preoperative deep vein thrombosis (pre-DVT) is a risk of symptomatic venous thromboembolism (VTE) and a serious postoperative surgical complication. However, little is known about pre-DVT in patients undergoing surgery. This study aimed to i
Externí odkaz:
https://doaj.org/article/c47ed8272ac6440a854b3e1086564b6c